Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

FDA grants orphan drug designation to Pharmion and MethylGene's MGCD-0103

Aug. 23, 2007

Positive results for Antisoma's ASA-404 in phase II lung cancer trial

Aug. 23, 2007

Phenoxodiol may reduce cisplatin-induced neuropathy

Aug. 22, 2007

FDA approvable letter issued for Indevus' drug candidate Valstar

Aug. 22, 2007

Cell Therapeutics to acquire Zevalin from Biogen Idec for U.S. sales and marketing

Aug. 22, 2007

New anticancer agents claimed by several research groups

Aug. 22, 2007

EMEA reviews new indication for Bioenvision's Evoltra

Aug. 21, 2007

FDA grants fast track designation to Adventrx's CoFactor

Aug. 21, 2007

Myriad begins third phase II trial of Azixa for lung cancer spread to the brain

Aug. 21, 2007

Recent patents cover HDAC inhibitors primarily for cancer

Aug. 21, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...